Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

127 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Belgian Competition Authority Issues Guidance On Information Exchange Between Pharmaceutical Companies For Combination Therapies

    On 10 September 2025, the Belgian Competition Authority (the BCA) published a communication clarifying the conditions under which pharmaceutical companies may exchange information...
    BelgiumAntitrust/Competition Law
    A&O Shearman
    A&O Shearman
  • Article

    Combination Therapies In Belgium: How To Collaborate Without Breaching Competition Law

    As the landscape of modern medicine evolves, combination therapies—those that use two or more distinct medicines, often from different companies...
    BelgiumAntitrust/Competition Law
    ALTIUS
ALTIUS
  • Article

    Minister For Social Affairs And Public Health Concludes "Pact For Future" With Pharmaceutical Industry

    On 27 July 2015, the Minister for Social Affairs and Public Health, Maggie De Block ("the Minister"), and the pharmaceutical sector umbrella organisations pharma.be and FeBelGen entered into a "Pact for the Future"...
    BelgiumFood, Drugs, Healthcare, Life Sciences
    Van Bael & Bellis
    Van Bael & Bellis
  • Article

    Commission Adopts The First-Ever International Definition Of Nanomaterials For Regulatory Purposes

    The European Commission's hesitation to provide a legal definition of nanomaterials came to an end last week when its services adopted and released a long-awaited and much-debated recommendation for a regulatory definition for nanomaterials on 18 October.
    European UnionFood, Drugs, Healthcare, Life Sciences
    White & Case
    White & Case
  • Article

    Ambitious Reform Of The Medical Devices Regulatory Framework

    The medical devices sector covers a wide range of products, from simple bandages to highly sophisticated devices such as pacemakers, as well as contact lenses, prostheses, medical equipment for hospital use, etc.
    BelgiumFood, Drugs, Healthcare, Life Sciences
    NautaDutilh
    NautaDutilh
  • Article

    Belgium Advances Digital Health As Its Parliament Calls For Action

    The Belgian Parliament's House of Representatives (HoR) has adopted a legislative resolution aimed at enhancing the accessibility and affordability of digital health applications (the Resolution).
    BelgiumFood, Drugs, Healthcare, Life Sciences
    Osborne Clarke LLP
    Osborne Clarke LLP
  • Article

    Unveiling The Complexity Of The Belgian MedTech Legal Landscape

    The Belgian regulatory framework for medical devices is highly complex, and the already dense legal landscape was recently added to by the adoption of two new Belgian royal decrees...
    BelgiumFood, Drugs, Healthcare, Life Sciences
    Crowell & Moring LLP
    Crowell & Moring LLP
  • Article

    EU Pharma Package: Global (Orphan) Marketing Authorization Compromise Proposal

    In our fifth alert in this EU Pharma Package Series, we provided an analysis of the background and ongoing legal debates regarding the concept of the global marketing authorization (GMA).
    European UnionFood, Drugs, Healthcare, Life Sciences
    Crowell & Moring LLP
    Crowell & Moring LLP
  • Article

    Preparing For The EU's New Approach To Critical Medicines And Medicine Shortages: A New 'Critical Medicines Act'?

    The EU legal and policy framework regarding critical medicines and medicine shortages is rapidly changing. In the past 12 months alone, there have been numerous developments...
    European UnionFood, Drugs, Healthcare, Life Sciences
    Crowell & Moring LLP
    Crowell & Moring LLP
  • Article

    The EU Pharma Package: The Transferable Exclusivity Voucher Compromise Proposal

    Addressing antimicrobial resistance (AMR) is one of the key objectives of the EU’s legislative reform. However, the development pipeline for new effective antimicrobials is obstructed, primarily due to a profound market failure: the low commercial value of the antimicrobial medicinal product market (costly development versus naturally limited market). In short, the market alone cannot deliver the solutions urgently needed to address AMR.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Crowell & Moring LLP
    Crowell & Moring LLP
  • Article

    ECJ Clarifies Concept Of "Human Embryo" Within Meaning Of Biotech Directive

    In the facts underlying the case at hand, ISCC sought to register two UK patents relating to unfertilized human ova which have been stimulated to divide in the absence of sperm.
    European UnionIntellectual Property
    Van Bael & Bellis
    Van Bael & Bellis
  • Article

    Will Government's Approach To The Adoption Of The NHI Do More Harm Than Good?

    The Minister of Health, Dr Aaron Motsoaledi (Minister), has been entrusted with the unenviable task of overseeing South Africa's transition to universal health coverage
    BelgiumFood, Drugs, Healthcare, Life Sciences
    Hogan Lovells
    Hogan Lovells
  • Article

    EU Reaches Pharma Package Deal: Key Changes At A Glance

    On 11 December 2025, following overnight negotiations, the Council and the European Parliament announced a political agreement on the long-awaited Pharma Package (see here).
    BelgiumFood, Drugs, Healthcare, Life Sciences
    ALTIUS
    ALTIUS
  • Article

    EMA Adopts Revised CTIS Transparency Rules

    On 5 October 2023, the European Medicines Agency (EMA) adopted revised transparency rules for the publication of information on clinical trials submitted through the Clinical Trials Information System (CTIS).
    European UnionPrivacy
    Cooley LLP
    Cooley LLP
  • Article

    EU Confirms App Stores And Developers Are Subject To Medical Device Laws

    The latest MDCG guidelines highlight a regulatory environment in the EU that is growing in depth and reach for software-based medical devices and diagnostics
    European UnionFood, Drugs, Healthcare, Life Sciences
    Osborne Clarke LLP
    Osborne Clarke LLP
  • Article

    EU Guidance Details How Technical And Clinical Standards Converge For AI In Medtech

    FAQ explains research exemption, dual conformity assessment and clinical data obligations for devices and diagnostics
    European UnionFood, Drugs, Healthcare, Life Sciences
    Osborne Clarke LLP
    Osborne Clarke LLP
  • Article

    European Commission Publishes Proposal For EU Critical Medicines Act

    On 11 March 2025, the European Commission published a proposal for a Critical Medicines Act (CMA).
    European UnionFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    EMA's Notice On Validation And Qualification Of Software Tools Used In Clinical Trials

    On 7 April 2020, the European Medicines Agency (EMA) issued a Notice to sponsors on validation and qualification of computerised systems used in clinical trials (Notice).
    BelgiumFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    The European Commission Releases An Updated Borderline Manual For Medical Devices

    The European Commission has updated the Manual on borderline and classification in the community regulatory framework for medical devices (Borderline Manual)
    BelgiumFood, Drugs, Healthcare, Life Sciences
    Hogan Lovells
    Hogan Lovells
  • Article

    EU Competitiveness Report Pushes For Greener And Digitalised Medical And IVD

    The European Commission's report this September on the future of European competitiveness provides critical insights into the economic, regulatory, and technological challenges facing various industries...
    European UnionFood, Drugs, Healthcare, Life Sciences
    Osborne Clarke LLP
    Osborne Clarke LLP
  • Showing 61–80 of 127 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics